Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 214 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Liakopoulos, Vassilios [Clear All Filters]
Kidney Health for Everyone Everywhere-From Prevention to Detection and Equitable Access to Care..
J Ren Care. 46(1), 4-12.
(2020). Kidney health for everyone everywhere-From prevention to detection and equitable access to care..
Nephrology (Carlton). 25(3), 195-201.
(2020). Kidney Health for Everyone, Everywhere-from prevention to detection and equitable access to care..
Nephrol Dial Transplant. 35(3), 367-374.
(2020). Kidney Health for Everyone Everywhere-From Prevention to Detection and Equitable Access to Care..
Kidney Int Rep. 5(3), 245-251.
(2020).
(2016). Late onset of clinically apparent central vein stenosis due to previous central venous catheter in a patient with inherited thrombophilia..
Hemodial Int. 18(2), 540-3.
(2014). Late-onset Pompe's disease in a hemodialysis patient: A first case report..
Hemodial Int. 22(2), E23-E25.
(2018). Like total ghrelin, acylated ghrelin is also lower in HD patients with cardiovascular disease..
Kidney Int. 80(7), 783; author reply 783-4.
(2011). Low-dose combination therapy to control sustained ambulatory hypertension-Basic principles and future directions..
J Clin Hypertens (Greenwich). 21(2), 249-251.
(2019). Measures of frequency and effect in clinical research..
Int Urol Nephrol.
(2023). Melatonin secretion is impaired in women with preeclampsia and an abnormal circadian blood pressure rhythm..
Ren Fail. 36(7), 1001-7.
(2014). Mineralocorticoid Antagonists in ESRD: An Overview of Clinical Trial Evidence..
Curr Vasc Pharmacol. 15(6), 599-606.
(2017). Mineralocorticoid Receptor Antagonism for Cardiovascular Protection in End-Stage Renal Disease: New Data But the Controversy Continues..
J Clin Hypertens (Greenwich). 18(3), 197-9.
(2016).
(2020). N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients-focus on the antioxidant and anti-inflammatory properties..
Int Urol Nephrol. 55(6), 1481-1492.
(2023). Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension..
Hypertens Res. 42(7), 1001-1010.
(2019).
(2010).
(2010). Optimal diastolic blood pressure range in intensive systolic targets: Resolving the controversy between observational and intention-to-treat analyses..
J Clin Hypertens (Greenwich). 21(7), 919-921.
(2019). Osteoporosis after renal transplantation..
Int Urol Nephrol. 47(3), 503-11.
(2015). Is oxidative stress an issue in peritoneal dialysis?.
Semin Dial. 32(5), 463-466.
(2019). Oxidative Stress and Acute Kidney Injury in Critical Illness: Pathophysiologic Mechanisms-Biomarkers-Interventions, and Future Perspectives..
Oxid Med Cell Longev. 2017, 6193694.
(2017). Oxidative Stress and the Kidney in the Space Environment..
Int J Mol Sci. 19(10),
(2018). Oxidative stress in hemodialysis: Causative mechanisms, clinical implications, and possible therapeutic interventions..
Semin Dial. 32(1), 58-71.
(2019). Oxidative Stress in Hemodialysis Patients: A Review of the Literature..
Oxid Med Cell Longev. 2017, 3081856.
(2017).